[The effects of vasodilators on the cerebral hemodynanics in the cerebrovascular diseases].
D000328:Adult; D000368:Aged; D002245:Carbon Dioxide / Q000097:blood; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000503:physiopathology*; D003510:Cyclohexanes / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008333:Mandelic Acids / Q000494:pharmacology; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010208:Papaverine / Q000008:administration & dosage / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D015016:Yohimbine / Q000494:pharmacology
D003510:Cyclohexanes; D006634:Histamine H1 Antagonists; D008333:Mandelic Acids; D010879:Piperazines; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D015016:Yohimbine; D010208:Papaverine; D010100:Oxygen